These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19124825)

  • 1. Empirical use of fluconazole in critically ill patients: good study, but what was the hold-up?
    Shelburne SA
    Ann Intern Med; 2009 Jan; 150(1):58-9; author reply 59-60. PubMed ID: 19124825
    [No Abstract]   [Full Text] [Related]  

  • 2. Empirical use of fluconazole in critically ill patients: good study, but what was the hold-up?
    Lee DH
    Ann Intern Med; 2009 Jan; 150(1):59; author reply 59-60. PubMed ID: 19124827
    [No Abstract]   [Full Text] [Related]  

  • 3. Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial.
    Schuster MG; Edwards JE; Sobel JD; Darouiche RO; Karchmer AW; Hadley S; Slotman G; Panzer H; Biswas P; Rex JH
    Ann Intern Med; 2008 Jul; 149(2):83-90. PubMed ID: 18626047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal prophylaxis for intensive care unit patients: let's fine tune it.
    Calandra T; Marchetti O
    Intensive Care Med; 2002 Dec; 28(12):1698-1700. PubMed ID: 12580153
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluconazole for the prevention of fungal infections: get ready, get set, caution.
    Fanaroff AA
    Pediatrics; 2006 Jan; 117(1):214-5. PubMed ID: 16396881
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral nystatin as antifungal prophylaxis in critically ill patients: an old SDD tool to be renewed?
    Eggimann P; Wolff M; Garbino J
    Intensive Care Med; 2005 Nov; 31(11):1466-8. PubMed ID: 16195906
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolving role of early antifungals in the adult intensive care unit.
    Lam SW; Eschenauer GA; Carver PL
    Crit Care Med; 2009 May; 37(5):1580-93. PubMed ID: 19325484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing Candida infections during neonatal intensive care: management choices, infection control, and fluconazole prophylaxis.
    Long SS; Stevenson DK
    J Pediatr; 2005 Aug; 147(2):135-41. PubMed ID: 16126036
    [No Abstract]   [Full Text] [Related]  

  • 9. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
    Kramer KM; Skaar DJ; Ackerman BH
    Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of fluconazole in neonatal intensive care units.
    Manzoni P; Mostert M; Jacqz-Aigrain E; Farina D
    Arch Dis Child; 2009 Dec; 94(12):983-7. PubMed ID: 19723639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prophylaxis of candidosis in case of secondary immunodeficiency].
    Kolbin AS; Ivanov DO; Shabalov NP; Klimko NN; Karpov OI
    Antibiot Khimioter; 2003; 48(4):35-9. PubMed ID: 13677136
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylactic fluconazole in liver transplant recipients: a randomized, double-blind, placebo-controlled trial.
    Patel R
    Liver Transpl; 2000 May; 6(3):376-9. PubMed ID: 10827245
    [No Abstract]   [Full Text] [Related]  

  • 13. The answer is in: fluconazole prophylaxis is not beneficial for intensive care unit patients without neutropenia.
    Fekete T
    Ann Intern Med; 2008 Jul; 149(2):140-1. PubMed ID: 18626054
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants.
    Bertini G; Perugi S; Dani C; Filippi L; Pratesi S; Rubaltelli FF
    J Pediatr; 2005 Aug; 147(2):162-5. PubMed ID: 16126042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive candidiasis in the ICU: evidence based and on the edge of evidence.
    Hollenbach E
    Mycoses; 2008 Sep; 51 Suppl 2():25-45. PubMed ID: 18721330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
    Playford EG; Webster AC; Sorrell TC; Craig JC
    J Antimicrob Chemother; 2006 Apr; 57(4):628-38. PubMed ID: 16459344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination.
    Garbino J; Lew DP; Romand JA; Hugonnet S; Auckenthaler R; Pittet D
    Intensive Care Med; 2002 Dec; 28(12):1708-17. PubMed ID: 12447512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluconazole prophylaxis.
    Ho KM
    Crit Care Med; 2006 Feb; 34(2):584-5; author reply 585-6. PubMed ID: 16424775
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylactic oral antifungal agents to prevent systemic candida infection in preterm infants.
    Austin NC; Darlow B
    Cochrane Database Syst Rev; 2004; (1):CD003478. PubMed ID: 14974017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole prophylaxis for critically ill patients at high risk for Candida infection.
    Garbino J
    Clin Infect Dis; 2005 Dec; 41(11):1690-1. PubMed ID: 16267753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.